Guangdong Vtr Bio-Tech Co.,Ltd.’s Net Profit Dropped 54.9% in First Three Quarters of 2022

Guangdong Vtr Bio-Tech Co.,Ltd. (广东溢多利生物科技股份有限公司) (300381.SZ) reported a net profit of 43.1 million yuan in the first three quarters of 2022, down 54.9% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 25.9% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 261.1 million yuan in total liabilities, with a liability-to-asset ratio of 8.4%.